Tenderwize
Zurück zur Suche

Open house discount agreements for the active ingredient Baricitinib, ATC L04AF02

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 186 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Baricitinib, ATC L04AF02

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

40 / 100

Komplexität

20 / 100

Risikofaktoren

The buyer reserves the right to replace open-house contracts with exclusive discount agreements at any time, automatica...

No commitment on minimum quantities or volumes; actual uptake depends on prescribing behavior and patient needs.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of pharmaceutical products containing Baricitinib
  • Non-exclusive discount agreements under §130a Abs. 8/130c Abs. 1 SGB V
Vollständige Zusammenfassung anzeigen

This is an open-house model for non-exclusive discount agreements (Rabattverträge) on the active ingredient Baricitinib (ATC L04AF02) by AOK Rheinland-Pfalz/Saarland. The procedure is not a formal EU procurement but a voluntary transparency publication. All interested pharmaceutical companies can join at any time during the 24-month maximum contract duration, with first possible start on 01.05.2025. No estimated value is provided. The contract may be replaced by exclusive agreements during its term.

Risiken

The buyer reserves the right to replace open-house contracts with exclusive discount agreements at any time, automatica...

No commitment on minimum quantities or volumes; actual uptake depends on prescribing behavior and patient needs.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Pharmaceutical companies only
  • Products must be authorized and marketable in Germany
  • Proof of marketability via Lauer-Taxe listing or AMIce database

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No award criteria specified; all participants are accepted under uniform conditions.

Auftraggeber

Lose (1)

LOT-0001

Open house discount agreements for the active ingredient Baricitinib, ATC L04AF02

Non-exclusive discount agreements for Baricitinib. All pharmaceutical companies can participate under uniform conditions. Contracts run for up to 24 months, starting 01.05.2025. The buyer may replace these with exclusive contracts at any time. First deadline for initial agreements: 31.03.2025; thereafter, monthly deadlines apply.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

Apr 2025 - Apr 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

No award criteria specified; all participants are accepted under uniform conditions.

Frist

Expired Mar 31, 2025

Vergabedetails

Veröffentlichungsdatum
12 Mar 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
164264-2025

Dokumente (1)

Ähnliche Ausschreibungen